Lupin unveils partial onset seizures drug Eslicarbazepine Acetate in US Ruchika Sharma8 May 2025 12:01 PM IST Mumbai: Global pharma major Lupin Limited has announced that the company has launched Eslicarbazepine Acetate Tablets, 200 mg, 400 mg, 600...
Lupin gets green light from USFDA for kidney drug Tolvaptan Ruchika Sharma24 April 2025 11:52 AM ISTMumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S. FDA) for...
Lupin recalls over 2000 bottles of antidepressant medication in US Ruchika Sharma23 April 2025 3:09 PM ISTUS: Lupin Pharmaceuticals Inc, a US-based subsidiary of Mumbai-headquartered Lupin is recalling over 2000 bottles of an antidepressant...
USFDA issues EIR for Lupin Nagpur Injectable facility Ruchika Sharma17 April 2025 3:00 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the United States Food...
Lupin UK arm acquires Renascience Pharma for over Rs 138 crore Ruchika Sharma3 April 2025 1:30 PM ISTMumbai: Lupin Healthcare (UK) Limited, the wholly owned subsidiary of global pharma major Lupin Limited, has announced the acquisition of ...
Lupin three senior executives to retire in 2 days Ruchika Sharma29 March 2025 12:15 PM ISTMumbai: Global pharmaceutical giant Lupin has announced the retirement of its three senior executives.Naresh Gupta, President – API Plus &...
Lupin awarded EcoVadis Silver Medal for sustainability excellence Ruchika Sharma21 March 2025 2:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has been awarded "Silver Medal" by EcoVadis for its outstanding sustainability...
Lupin bags tentative USFDA nod for rare autoimmune disorder drug Amifampridine Ruchika Sharma17 March 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin unveils heart drug Rivaroxaban in US Ruchika Sharma8 March 2025 11:41 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of...
Lupin secures place in Prestigious S&P Global Sustainability Yearbook 2025 Ruchika Sharma2 March 2025 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, for the second...
USFDA issues EIR for Lupin Somerset facility Ruchika Sharma22 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has issued the...
Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea Ruchika Sharma11 Feb 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
